Physician profile
Timothy Chan
NPI 1538205620
$7,641.56
in general payments reported to CMS, 2019-2025
7 companies · $21.35 in 2025
The $21.35 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,600 · 2022: $3,020 · 2025: $21.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,300.00 | 2021-2022 | |
| Pfizer INC. | $2,700.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,600.00 | 2021 | |
| Ani Pharmaceuticals, INC. | $21.35 | 2025 | Iluvien |
| Siemens Medical Solutions USA, INC. | $20.21 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.